Tissue factor with age-related macular degeneration
- PMID: 23166874
- PMCID: PMC3484712
- DOI: 10.3980/j.issn.2222-3959.2012.05.13
Tissue factor with age-related macular degeneration
Abstract
Wet age-related macular degeneration which incidence increases year by year is a blinding eye disease, but current clinical methods of treatment on this disease are limited and the outcome is not ideal. Recent studies have found abnormally high expression of tissue factors which are targets for the treatment of wet age-related macular degeneration to achieve a certain effect in the choroidal neovascularization. Related literatures are reviewed as following.
Keywords: choroidal neovascularzation; immunotherapy; photodynamic therapy; tissue factor; wet age-related macular degeneration.
References
-
- Li D, Li QC, Sun M. Recent advances on treatment for neovascular age-related macular degeneration. Yanke Xinjinzhan. 2010;30(8):797–800.
-
- Croce K, Libby P. Intertwining of thromhosis and inflammation in atherosclerosis. Curr Opin Hematol. 2007;14(1):55–61. - PubMed
-
- Versteeg HH, Peppelenbosch MP, Spek CA. The pleiotropic effects of tissue factor: a possible role for factor VII a -induced intracellular signalling? Thromb Haemost. 2001;86:1353–1359. - PubMed
-
- Ambati J, Ambati BK, Yoo SH, Ianchulev S, Adamis AP. Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. Surv Ophthalmol. 2003;48(3):257–293. - PubMed
LinkOut - more resources
Full Text Sources